About Summits Connect
Summits Connect is a specialist conference and events company focused on the life sciences, biotechnology, pharmaceutical, and clinical research sectors. Our mission is to create high‑value platforms that connect industry leaders, innovators, regulators, service providers, and researchers to accelerate collaboration and innovation across the healthcare ecosystem.
Our inaugural flagship event, Clinical Trials Connect, is designed to become a leading annual gathering for professionals involved in clinical development, patient recruitment, decentralized trials, regulatory affairs, data management, and digital health technologies.
As we prepare for launch, we are seeking a strategic investor and co‑founder to help build a scalable events business serving one of the world's fastest‑growing industries.
The Opportunity
We are looking for an entrepreneurial investor, industry executive, angel investor, venture capitalist, or strategic partner who shares our vision and would like to participate in building a high‑growth events platform from the ground up.
This opportunity combines equity ownership with a hands‑on role in shaping the future direction of the business.
Key Responsibilities
- Provide seed capital to support the launch and growth of Clinical Trials Connect.
- Contribute to business strategy, fundraising, and market expansion initiatives.
- Leverage your network within life sciences, pharmaceuticals, biotechnology, CROs, healthcare technology, and investment communities.
- Support sponsor acquisition, partnership development, and strategic alliances.
- Assist in scaling the company into multiple industry‑focused events across Europe, North America, and the Middle East.
- Participate in key business decisions and long‑term growth planning.
What We Offer
- Equity ownership in Summits Connect, structured according to investment level and involvement.
- Co‑Founder status and a leadership role within the company.
- Opportunity to build a market‑leading brand within the life sciences events sector.
- Participation in future revenue streams from conferences, sponsorships, exhibitions, memberships, training programs, and digital communities.
- Significant upside potential as the company expands its portfolio and geographic reach.
Ideal Partner Profile
- Experience investing in early‑stage companies.
- Background in life sciences, biotechnology, pharmaceuticals, healthcare, or professional events.
- Established relationships with pharmaceutical companies, CROs, research institutions, healthcare technology firms, or investors.
- Strategic mindset and interest in helping scale a business beyond its initial launch phase.
- Based in the UK, Europe, North America, or open to a remote partnership model.
Investment Requirement
We are open to discussing investment opportunities ranging from £25,000 to £250,000+, depending on the level of involvement, strategic value, and equity structure.
All proposals will be considered on an individual basis.
Why This Market?
Strong Industry Fundamentals
- The global clinical trials industry represents a multi‑billion‑pound market and continues to expand as pharmaceutical and biotechnology innovation accelerates.
- Demand for industry networking, partnership development, and knowledge‑sharing events continues to grow.
- Organizations increasingly rely on specialized conferences to identify partners, technologies, service providers, and investment opportunities.
- Sponsorship and exhibition revenues within life sciences events remain among the strongest across all B2B sectors.
Strategic UK Positioning
The United Kingdom remains one of the world's leading hubs for clinical research, biotechnology innovation, and pharmaceutical development. With access to major industry clusters, research institutions, and international stakeholders, Summits Connect is positioned to become a key platform serving this dynamic market.
Our Vision
To build the leading global event and community platform connecting clinical research, life sciences, biotechnology, and healthcare innovators through world‑class conferences, strategic partnerships, and year‑round engagement opportunities.
If you are interested in joining us at the beginning of this journey as an investor and strategic partner, we would welcome a confidential discussion.
